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POINT/COUNTERPOINT 
 
Suggestions for topics suitable for these Point/Counterpoint debates should be addressed 
to Colin G. Orton, Professor Emeritus, Wayne State University, Detroit: 
ortonc@comcast.net. Persons participating in Point/Counterpoint discussions are 5 
selected for their knowledge and communicative skill. Their positions for or against a 
proposition may or may not reflect their personal opinions or the positions of their 
employers. 
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OVERVIEW 
 
When companies fund research they obviously hope that the research will demonstrate 30 
the superior effectiveness of their products. Consequently, publication of negative results 
might make companies less enthusiastic about supporting such research in the future. 
Since researchers who use industrial support are likely to be eager to continue with this 
funding, some believe that this might increase the risk biased reporting. This is the 
premise debated in this month’s Point/Counterpoint. 35 
  
Arguing for the Proposition is Sonja Dieterich, Ph.D. After completing her Ph.D. in 
Nuclear Physics at Rutgers University in 2002, Dr. Dieterich received training in Medical 
Physics at Georgetown University Hospital, Washington DC, from 2002 to 2003. In 
2003, she accepted a faculty position at Georgetown. From 2007-2012, she worked at 40 
Stanford University Hospital as Clinical Associate Professor and Chief of Radiosurgery 
Physics. Currently she is an Associate Professor and Physics Residency Co-Director at 
the University of California Davis. Dr. Dieterich is Chair of the AAPM Task Group 135 
"QA for Robotic Radiosurgery" and a member of the ASTRO Physics and Multi-
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Disciplinary QA Committees. Her current research interests are the development of 45 
QA/QM programs for new technologies, image-guided brachytherapy, and veterinary 
radiation oncology.  
 
Arguing against the Proposition is Paul J. Keall, Ph.D.  Dr. Keall is a Professor at the 
University of Sydney in Australia. His work is broadly supported by the NHMRC 50 
Australia Fellowship Innovations in Medical Physics to Improve Human Health with 
additional funding supporting individual projects from Australian and US government 
sources. Prof. Keall’s main scientific interests involve image-guided radiation therapy 
and accounting for anatomic and physiologic changes in healthy and pathologic tissue 
throughout a radiation treatment course.  Additional areas of investigation include 55 
ventilation imaging, audiovisual biofeedback, and MRI-guided radiotherapy.  These 
research activities have resulted in over 170 scientific articles and several awards and 
honors.  He has developed new methods for medical imaging and image-guided radiation 
therapy that have been translated into clinical practice.  Relevant to this debate, and in the 
full disclosure spirit of TG109, to quote Rock Mackie “Dr. Keall is a poster-child for 60 
conflict-of-interest”, having held over 20 research agreements with start-up, mid-size and 
large companies along with awarded patents and commercial licenses. 
 
FOR THE PROPOSITION: Sonja Dieterich, Ph.D. 
 65 
Opening Statement 
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  As humans, we are hard-wired toward implicit bias.1 The Washington Post 
published on biased reporting in pharmaceutical research,2 which triggers some self-
examination about potential publication bias in medical physics. Let us assume that 
vendors and researchers have been able to avoid conscious bias exerted by pressures of 70 
market shares and up-or-out research faculty appointments which depend on securing 
ever scarcer grants. The issue of implicit bias still remains. To conduct good science, we 
must address all factors affecting the quality of science; publication bias is a major 
known factor to affect research quality, and with shrinking NIH budgets will only gain in 
influence. 75 
 A large body of research is available on publication bias. To summarize: (1) there 
is publication bias in medical journals toward positive outcomes,3 (2) the incidence of 
editors or reviewers rejecting negative studies is small for JAMA,4 but unknown for most 
other journals, and (3) published reports from industry-funded studies show a larger bias 
toward positive results.5 Unless medical physics journals (e.g. Medical Physics, PMB, 80 
JACMP) publish data to the contrary, my working hypothesis is for an existing 
editorial/reviewer bias of unknown size toward rejecting papers which report negative 
study outcomes. No reviewer guideline, journal review submission websites or our Code 
of Ethics6 addresses implicit bias toward positive study outcomes. 
 One proposed way to remove positive publication bias is to require all federally 85 
funded-research to be published independent of outcome, provided the scientific method 
and statistical analysis meet quality standards. It remains to be seen if industry would 
commit to this solution as well because, for such a commitment to be meaningful, 
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vendors would need to provide means of independent verification such as a publicly-
accessible listing of all outside research contracts. 90 
 Increased reliance on industry funding also increases the risk for comparative 
effectiveness research on technology to remain unfunded. Few institutions can afford the 
cost and redundancy of operating two or more technologies designed to perform the same 
function. For vendor-funded research, there is no incentive to compare clinical 
effectiveness of competing technologies. Instead, the implicit bias is toward research on 95 
the new technology vs. older technology. One clinical example is respiratory motion 
compensation. Several vendors provide solutions for each of the four techniques: 
compression, breath-hold, gating, and real-time tracking. Despite the widespread 
acceptance of these technologies and a large variation of cost to implement and use them, 
there is not a single prospective clinical trial which would provide data on patient 100 
outcomes based solely on the technology used for treatment.  
 
AGAINST THE PROPOSITION: Paul J. Keall, Ph.D. 
 
Opening Statement 105 
 As scientists we have a mandate to generate new scientific knowledge.  As 
medical physicists we perform and publish work that can improve how we detect, image, 
diagnose and treat disease.  However, our academic integrity struggles against biased 
reporting for any publication independent of its funding source: we have an inherent self-
interest in having articles published that help us get and keep grants, help with promotion 110 
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and career prospects, help with invitations to give talks at interesting places, and many 
other benefits.  As a result, for many reasons, a few of us ‘behave badly’.7 
Industry-funded research plays an important role in improving health outcomes, 
typically supporting medium-to-late stage research aligned with product roadmaps.  
Often late-stage research requires engineering support to allow clinical testing that 115 
otherwise would not be possible.  The potential for conflicts-of-interest exist.  
Fortunately, to avoid any undue influence of industry pressure on the outcomes of 
research, there are a number of mechanisms to protect and isolate researchers from 
external influences and therefore reduce the risk of biased reporting.  Three protection 
mechanisms reducing the risk of biased reporting are: (1) increased accountability from 120 
medical journals regarding ethics and conflicts of interest, (2) greater academic freedom 
in industrial-university agreements and (3) stronger governmental regulation of 
commercially-sponsored research. 
 
(1) Increased accountability from medical journals regarding ethics and conflicts of 125 
interest 
All reputable medical journals now have conflict of interest policies.  Many journals 
follow the ICMJE conflict-of-interest policy in which each author must submit a written 
signed disclosure.  Medical Physics requires that “Each author of a manuscript is required 
to disclose any and all potential conflicts of interest that could be perceived to bias the 130 
results reported in the manuscript.”  This policy raises awareness for authors submitting 
the work, reviewers and readers, and increases authors’ accountability.    
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(2) Greater academic freedom in industrial-university agreements 
Over time, universities have taken a much stronger stance with respect to research 135 
conduct and publication control.  An example from a University of Sydney agreement 
states: “As a matter of basic academic policy, the University retains the right to publish in 
its discretion material relating to the conduct and conclusions of the Research”, meaning 
that the academic staff have the right to publish and interpret their own results without 
industry direction or oversight.   140 
  
(3) Stronger governmental regulation of commercially sponsored research 
The US FDA, NIH and other government bodies have a vested interest in ensuring that 
publications of studies represent the actual results.  There is new and proposed regulation 
for conflicts of interest, assessing conflicts prior to the start of a study to potentially 145 
recuse investigators, avoid data falsification, and provide data storage and data access.  
An as example, NIH policy states: “This complexity, as well as a need to strengthen 
accountability, led to changes that expand and add transparency to Investigators’ 
disclosure of Significant Financial Interests (SFIs), enhance regulatory compliance and 
effective institutional oversight and management of Investigators’ financial conflicts of 150 
interests.”   
 In summary, medical journals, universities and governments are actively working 
to protect investigators from external influences and therefore decrease the risk of biased 
reporting in journals such as Medical Physics.   
 155 
Rebuttal: Sonja Dieterich, Ph.D. 
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 Dr. Keall highlights the increased efforts to address biased reporting in science.  
The questions we need to evaluate are: How effective are we in enforcing these rules, and 
have we done enough to cause a change in our culture? To use an analogy, the posted 
speed limit is the rule, but the unwritten culture (on most highways in the USA, Germany 160 
and Australia at least) is for traffic to proceed at 10 miles-per-hour above the posted 
speed limit without fear of repercussion by the highway patrol. 
 Dr. Keall cited a very good paper published in 2005,7 which I have examined for 
data pertaining to funding source influence on outcome reporting, i.e. violation of 
scientific integrity standards. Table 1, entry 10 in this paper lists the incidence of 165 
“Changing the design, methodology, or results of a study in response to pressure from a 
funding source” as 15.5% on average (9.5% for early career and 20.6% for mid-career 
scientists). Given that the study plausibly argues the under-reporting of results, these 
percentages hardly constitute just a few of us behaving badly, as my opponent states. I 
was unable to find data suggesting this percentage had decreased with the implementation 170 
of the three protection mechanisms Dr. Keall listed. 
 To be effective in making science less prone to bias, the interventions must (1) 
remove the motivation for biased behavior, (2) implement a means of identifying 
researchers who do not follow scientific standards, and (3) increase the stakes for being 
found in violation of scientific standards. None of the three interventions listed by Dr. 175 
Keall remove the motivation for biased behavior. Indeed, decreasing support through 
outcome-neutral funding sources has increased the pressure. The second intervention, 
greater freedom to publish, looks good on paper but in reality will not protect the 
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researcher from losing continued industry sponsorship should negative outcome reporting 
be undesired by industry.  180 
 In summary, while gross scientific misconduct through fabrication, falsification 
and plagiarism is indeed committed by very few of us, I (pessimistically) maintain that 
our scientific culture has not yet changed sufficiently to remove the significant pressure 
towards biased reporting. We neither have data to allow us to make a conclusive 
statement that biased reporting is not an issue, nor do we have any auditing procedures in 185 
place to raise the stakes for breaking the rules. 
 
Rebuttal: Paul J. Keall, Ph.D. 
 Dr. Dieterich has some very good points and suggestions to improve the amount 
of negative-result research being published and the impact of declining Federal funding 190 
on clinically important research, such as comparative effectiveness studies.  She asserts 
that (1) humans are subject to bias, (2) there is evidence supporting publication bias, (3) 
Federally funded (and ideally industry-funded) research be published regardless of 
positive/negative results, and (4) the impact of increased reliance on industry funding 
means that some important research areas are unfunded.  These observations are all valid.  195 
However, they do not lead to the conclusion that increasing dependence on industry-
funded research creates higher risk of biased reporting in medical physics.  Moreover, 
several of the references used to support her statement pertain to the pharmaceutical 
world; none specifically address biased reporting in medical physics research.    
 To further the debate, the pathway to impacting patients on a large scale is 200 
necessarily through industry.  Having ideas proceed from bench to bedside is one of the 
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most rewarding professional accomplishments in our field.  Academic/industrial 
interactions are essential for this translational research.  AAPM TG1096 states “There is 
nothing inherently wrong with a conflict of interest, but it should be acknowledged to 
eliminate the perception of possible impropriety. The best protection against conflict of 205 
interest accusations is full disclosure and the acquisition, interpretation, and publication 
of research findings in a manner that is transparent and above suspicion.”  To navigate 
these interactions, in addition to the three protections reducing the risk of biased reporting 
detailed in my Opening Statement, researchers receive ethics education throughout their 
lives, along with a growing ethics component of graduate8 and residency9 medical 210 
physics programs and in our profession.6   
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